Pasireotide-d7

Pasireotide-d7 is a deuterated analog of the synthetic cyclic peptide pasireotide, designed for advanced research applications in the field of peptide and carbohydrate chemistry. Characterized by the presence of seven deuterium atoms, this isotopically labeled compound offers enhanced stability and unique mass spectrometric properties, making it a valuable tool in a variety of investigative contexts. Its structural similarity to native pasireotide allows it to retain essential binding characteristics, while the deuterium incorporation facilitates more precise tracking and quantification in complex biological matrices. Researchers value Pasireotide-d7 for its high degree of chemical definition and its ability to serve as a robust internal standard or tracer in analytical workflows. The compound's versatility extends to a broad range of experimental designs, supporting the elucidation of peptide-receptor interactions, metabolic profiling, and pharmacokinetic studies within preclinical research settings.

Analytical Standard in Mass Spectrometry: Pasireotide-d7 functions as an ideal internal standard for quantitative LC-MS/MS and GC-MS analyses, particularly in studies focused on peptide quantification within biological samples. Its deuterium labeling results in a distinct mass shift, allowing researchers to differentiate it from endogenous or unlabeled pasireotide during detection. This property enhances the accuracy and reproducibility of quantitative assays by compensating for sample preparation variability, matrix effects, and instrument fluctuations. Utilization of this labeled peptide as an internal standard streamlines method validation, supports rigorous quality control, and enables reliable comparison of peptide concentrations across multiple experimental runs.

Metabolic Stability and Degradation Pathway Studies: The unique isotopic composition of Pasireotide-d7 enables detailed investigations into the metabolic fate of peptide drugs. By tracking the deuterium label, researchers can delineate metabolic pathways, identify degradation products, and assess the stability of pasireotide analogs under various physiological conditions. These studies are critical for understanding peptide biotransformation, optimizing formulation strategies, and predicting in vivo behavior in animal models. The ability to distinguish between labeled and unlabeled species provides a powerful approach for mapping enzymatic cleavage sites and evaluating the impact of structural modifications on metabolic resistance.

Receptor Binding and Ligand Interaction Analysis: In receptor binding assays, Pasireotide-d7 offers a precise means to study ligand-receptor interactions without interference from endogenous peptides. The deuterated analog can be employed in competitive binding experiments to characterize affinity, specificity, and kinetics of peptide-receptor engagement. Researchers benefit from the ability to directly compare the binding profiles of native and labeled peptides, facilitating the design of structure-activity relationship (SAR) studies and the development of novel analogs with improved pharmacological properties. The use of isotopically labeled peptides in these assays enhances the resolution and interpretability of binding data, supporting advanced drug discovery efforts.

Pharmacokinetic and Biodistribution Profiling: Pasireotide-d7 is instrumental in preclinical pharmacokinetic research, where it serves as a tracer to monitor absorption, distribution, metabolism, and excretion (ADME) parameters. The deuterium label allows for selective detection in plasma, tissue, and excreta samples, enabling precise quantification of peptide concentrations over time. These studies provide critical insights into bioavailability, tissue targeting, and clearance mechanisms, informing the rational design of peptide-based therapeutics. The reliable differentiation of labeled analogs in complex biological matrices streamlines data interpretation and supports the development of predictive pharmacokinetic models.

Peptide Synthesis and Quality Control: The availability of Pasireotide-d7 as a reference material supports rigorous quality assurance in peptide synthesis laboratories. It can be used to verify the identity and purity of synthesized peptides through co-elution experiments and mass spectrometric comparison. The compound's well-defined isotopic signature aids in detecting minor impurities or degradation products, ensuring the consistency and reproducibility of peptide batches. Incorporation of this internal standard into analytical workflows enhances the reliability of peptide manufacturing processes and supports compliance with research quality requirements.

Structural Elucidation and Mechanistic Studies: Researchers leverage Pasireotide-d7 in mechanistic investigations aimed at elucidating structure-function relationships within peptide analogs. The presence of deuterium atoms facilitates advanced spectroscopic analyses, such as NMR and isotope-edited mass spectrometry, providing insights into conformational dynamics, molecular interactions, and chemical reactivity. These studies contribute to a deeper understanding of peptide behavior under varying environmental conditions, guiding the rational design of next-generation peptide compounds with tailored properties for research and development.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line